HFS-LTP decrement observed in the 12-month-old saline-treated 3xTg-AD siblings was prevented in the VU01-treated cohort (**** p < 0.0001; Figure 5A,B) despite the progressive load of Aβ and tau-driven synaptic toxicity. The gene discussed is MAPT; the disease is Alzheimer disease.